Magen BioSciences is focused on improving the health and appearance of human skin. Magen pursues a science-driven approach to identify and develop novel therapeutics to treat a number of large, poorly served dermatological disorders. The company has assembled an outstanding science, investor and management team. The team
includes co-founders of Idexx, Immunex, Alnylam, Momenta, Vertex, Biogen and Genzyme. The company is headquartered
in Massachusetts.
Press
release
Magen Scientific Founder Named Chairman of Dermatology at MGH
Press
release
Magen BioSciences Licenses Dermatology Assets from Lilly